---
document_datetime: 2023-10-31 10:48:11
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tobi-podhaler-epar-all-authorised-presentations_en.pdf
document_name: tobi-podhaler-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8215235
conversion_datetime: 2025-12-28 08:54:40.398992
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form             | Route of Administration   | Packaging         | Package size                                              |
|-----------------|-----------------|------------|---------------------------------|---------------------------|-------------------|-----------------------------------------------------------|
| EU/1/10/652/001 | TOBI Podhaler   | 28 mg      | Inhalation powder, hard capsule | Inhalation use            | blister (alu/alu) | 56 capsules + 1 inhaler                                   |
| EU/1/10/652/002 | TOBI Podhaler   | 28 mg      | Inhalation powder, hard capsule | Inhalation use            | blister (alu/alu) | 224 (4x 56) capsules + 5 inhalers (monthly multipack)     |
| EU/1/10/652/003 | TOBI Podhaler   | 28 mg      | Inhalation powder, hard capsule | Inhalation use            | blister (alu/alu) | 448 (8x 56) capsules +10 inhalers (2 x monthly multipack) |